The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cidomycin Paediatric 20mg/2ml Solution for Injection

20 mg/2ml Solution for injection

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/036/004

Main Information

Trade NameCidomycin Paediatric 20mg/2ml Solution for Injection
Active SubstancesGentamicin sulfate
Strength20 mg/2ml
Dosage FormSolution for injection
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/036/004

Group Information

ATC CodeJ01GB Other aminoglycosides
J01GB03 gentamicin

Status

Authorised/WithdrawnAuthorised
Licence Issued09/03/1977
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back